Results 281 to 290 of about 681,261 (380)
Elevated levels of PAI-1 precede the occurrence of type 2 diabetes mellitus. [PDF]
Hernestål-Boman J+6 more
europepmc +1 more source
New horizons in the pharmacological management of venous thromboembolism
Abstract Many patients suffer from venous thromboembolism (VTE) and its consequences. Despite substantial advancements with the introduction of direct oral anticoagulants (DOACs), patients and clinicians still encounter challenges in the acute and long‐term management of VTE, such as recurrent events, anticoagulant‐related bleeding complications, and ...
Andreas Verstraete+3 more
wiley +1 more source
Diagnostic value of tissue plasminogen activator-inhibitor complex in sepsis-induced liver injury: A single-center retrospective case-control study. [PDF]
Zhou Y+7 more
europepmc +1 more source
Abstract Background and Aims Observational studies frequently report co‐occurrence between endocrine, nutritional, and metabolic disease (ENMD) and pulmonary tuberculosis (PTB). However, the causal properties between them remain poorly defined. Our aim in this study was to investigate the causal effect of ENMD on PTB using Mendelian randomization ...
Yan Gao+5 more
wiley +1 more source
Exploring the efficacy of recombinant human pro-urokinase in catheter-directed thrombolysis for acute lower extremity deep venous thrombosis patients. [PDF]
Ma T, Li C, Song G, Yao S.
europepmc +1 more source
Recombinant enolase and 16.5 tegumentary proteins from F. hepatica EVs may influence the progression of fibrosis, altering cell growth, proteomic profiles, and EVs secretion in macrophages, hepatic stellate cells (HSCs) and hepatocytes. r‐Fhenolase reduced fibrosis markers in HSCs and exhibited anti‐inflammatory properties in macrophages, and r‐Fh16 ...
Aránzazu González‐Arce+4 more
wiley +1 more source
Potential therapeutic mechanisms of <i>Draconis Resina</i> in cardiovascular diseases-a narrative review. [PDF]
Wang J+5 more
europepmc +1 more source